A Study to Test an Oral Medicine, Belumosudil, in Combination With Corticosteroids in Participants at Least 12 Years of Age With Newly Diagnosed Chronic Graft Versus Host Disease.

Investigational Site Number : 0400004, Vienna

Cliniques Universitaires St. Luc-Investigational Site Number : 0560005, Woluwe

Investigational Site Number : 0320005, Buenos Aires

Investigational Site Number : 0320003, Buenos Aires

Investigational Site Number : 0320001, Buenos Aires

Investigational Site Number : 0320002, Buenos Aires

Investigational Site Number : 0320006, Pilar

Rigshospitalet Copenhagen University Hospital-Investigational Site Number : 2080002, Copenhagen

Investigational Site Number : 0360005, Westmead

Investigational Site Number : 0360001, Melbourne

UZ Leuven-Investigational Site Number : 0560001, Leuven

CHU de Liège-Investigational Site Number : 0560004, Liège

Investigational Site Number : 0400001, Linz

Investigational Site Number : 0360003, Brisbane

Investigational Site Number : 0320004, Córdoba

Odense University Hospital-Investigational Site Number : 2080003, Odense

Investigational Site Number : 0360004, Murdoch

Investigational Site Number : 0560006, Bruges

Investigational Site Number : 0400003, Graz

Department of hematology-Investigational Site Number : 2080001, Aarhus

AZ Delta-Investigational Site Number : 0560002, Roeselare

UZ Gent-Investigational Site Number : 0560003, Ghent

Investigational Site Number : 3800007, Turin

Institut Paoli Calmettes-Investigational Site Number : 2500004, Marseille

Investigational Site Number : 2760007, Berlin

UPMC Hillman Cancer Center- Site Number : 8400008, Pittsburgh

Investigational Site Number : 3800005, Genoa

Investigational Site Number : 3800002, Rozzano

Investigational Site Number : 3800009, Milan

Investigational Site Number : 2760002, Hamburg

Johns Hopkins Hospital- Site Number : 8400033, Baltimore

University of Virginia Comprehensive Cancer Center-Site Number : 8400031, Charlottesville

Investigational Site Number : 2760010, Kiel

Investigational Site Number : 3800003, Bergamo

Investigational Site Number : 3800011, Pavia

Atrium Health Wake Forest Baptist Medical Center - Winston-Salem - Medical Center Boulevard- Site Number : 8400007, Winston-Salem

UNC Children's Hospital- Site Number : 8400025, Chapel Hill

Investigational Site Number : 7240004, Madrid

Hospital Niño Jesús-Site Number : 7240002, Madrid

Hospital Regional Universitarioa de Malaga-Site Number : 7240003, Málaga

The Hope Clinic of Emory University- Site Number : 8400020, Decatur

AdventHealth Orlando- Site Number : 8400023, Orlando

Investigational Site Number : 3800008, Udine

CHU Bordeaux-Hôpital Haut-Lévêque-Investigational Site Number : 2500002, Pessac

Investigational Site Number : 7920005, Istanbul

Hôpital Pontchaillou - CHU de Rennes-Investigational Site Number : 2500008, Rennes

Investigational Site Number : 7920003, Izmir

Hospital Universitario de Salamanca-Site Number : 7240007, Salamanca

Sarah Cannon Research Institute Site Number : 8400003, Nashville

Investigational Site Number : 7240011, Santander

Investigational Site Number : 3800004, Bologna

University of Kentucky Chandler Medical Center- Site Number : 8400024, Lexington

Hospital Universitario Virgen del Rocío.-Site Number : 7240008, Seville

The Ohio State University Comprehensive Cancer Center (OSUCCC) - The James Cancer Hospital and Solove Research Institute- Site Number : 8400026, Columbus

CHU Hotel Dieu-Investigational Site Number : 2500005, Nantes

Oncology Hematology Care - Kenwood- Site Number : 8400030, Cincinnati

Investigational Site Number : 7240012, Valencia

Hospital Universitari i Politècnic La Fe-Site Number : 7240001, Valencia

Indiana University Health University Hospital- Site Number : 8400006, Indianapolis

Investigational Site Number : 2760009, Münster

Karmanos Cancer Institute - Detroit- Site Number : 8400013, Detroit

IV. Interni hematologicka klinika, Fakultni nemocnice Hradec Kralove-Site Number : 2030002, Hradec Králové

Investigational Site Number : 2760003, Cologne

University of Wisconsin Carbone Cancer Center-Site Number : 8400029, Madison

Investigational Site Number : 2500006, Vandœuvre-lès-Nancy

Investigational Site Number : 3800012, Torette

Northwestern University- Site Number : 8400017, Chicago

Interni hematologicka a onkologicka klinika Fakultni nemocnice Brno-Site Number : 2030003, Brno

Hôpital Lyon Sud-Investigational Site Number : 2500007, Pierre-Bénite

Klinika hematoonkologie, Fakultni nemocnice Ostrava-Site Number : 2030001, Ostrava

Investigational Site Number : 2760008, Tübingen

University of Arkansas for Medical Sciences-Site Number : 8400019, Little Rock

Investigational Site Number : 2500003, Paris

Texas Oncology - Dallas - Worth Street- Site Number : 8400010, Dallas

Investigational Site Number : 2500001, Paris

Texas Transplant Institute - Methodist Hospital- Site Number : 8400037, San Antonio

St. David's South Austin Medical Center- Site Number : 8400002, Austin

Investigational Site Number : 2760005, Freiburg im Breisgau

Investigational Site Number : 3800006, Reggio Calabria

City of Hope National Medical Center- Site Number : 8400001, Duarte

Investigational Site Number : 2760006, Regensburg

University of California San Francisco - Parnassus Heights- Site Number : 8400035, San Francisco

Oregon Health and Science University- Site Number : 8400027, Portland

Fred Hutchinson Cancer Research Center- Site Number : 8400004, Seattle

Investigational Site Number : 1560019, Beijing

Investigational Site Number : 1560012, Changchun

Investigational Site Number : 1560001, Suzhou

Investigational Site Number : 1560006, Suzhou

Investigational Site Number : 1560014, Hefei

Investigational Site Number : 1560008, Jinan

Investigational Site Number : 1560007, Jinan

Investigational Site Number : 1560003, Tianjin

Investigational Site Number : 1560004, Tianjin

Investigational Site Number : 1560002, Hangzhou

Investigational Site Number : 1560011, Fuzhou

Investigational Site Number : 1560010, Changsha

Investigational Site Number : 1560013, Wuhan

Investigational Site Number : 1560015, Wuhan

Investigational Site Number : 1560009, Zhengzhou

Investigational Site Number : 1560005, Guangzhou

Investigational Site Number : 3440001, Pok Fu Lam

Investigational Site Number : 3760002, Haifa

Investigational Site Number : 3760006, Petah Tikva

Investigational Site Number : 3760003, Ramat Gan

Investigational Site Number : 3760004, Ramat Gan

Investigational Site Number : 3760001, Tel Aviv

Investigational Site Number : 3760005, Jerusalem

Dana Farber Cancer Institute Site Number : 8400005, Boston

Hôpital Maisonneuve Rosemont-Investigational Site Number : 1240001, Montreal

CHU Sainte-Justine-Site Number : 1240003, Montreal

Investigational Site Number : 1240002, Montreal

Investigational Site Number : 1240008, Saskatoon

Ustav hematologie a krevni transfuze-Site Number : 2030004, Prague

Hospital de Clinicas da Universidade Federal do Parana- Site Number : 0760008, Curitiba

Fundação Faculdade Regional de Medicina de São José do Rio Preto- Site Number : 0760006, São José do Rio Preto

INCA - Hospital do Câncer - Rio de Janeiro - Praça Da Cruz Vermelha- Site Number : 0760007, Rio de Janeiro

Hospital das Clinicas FMUSP- Site Number : 0760004, São Paulo

Hospital Israelita Albert Einstein- Site Number : 0760003, São Paulo

Investigational Site Number : 1240007, Calgary

Investigational Site Number : 1240005, Toronto

Investigational Site Number : 2760001, Dresden

Nosokomeio Paidon I Agia Sofia-Site Number : 3000002, Athens

"General Hospital of Thessaloniki George Papanikolaou-Site Number : 3000001", Thessaloniki

Investigational Site Number : 3800001, Rome

Investigational Site Number : 3800010, Perugia

Amsterdam Universitair Medisch Centrum-Site Number : 5280005, Amsterdam

Investigational Site Number : 5280003, Groningen

Investigational Site Number : 5280002, Rotterdam

Investigational Site Number : 5280001, Utrecht

Investigational Site Number : 6160001, Gdansk

Investigational Site Number : 6160008, Szczecin

Investigational Site Number : 6200003, Lisbon

Investigational Site Number : 6200002, Lisbon

Investigational Site Number : 4100002, Seoul

Investigational Site Number : 4100003, Seoul

Investigational Site Number : 4100004, Seoul

Investigational Site Number : 4100001, Seoul

Investigational Site Number : 7240005, Barcelona

ICO Institut Català d'Oncologia-Site Number : 7240006, Barcelona

Investigational Site Number : 7520003, Gothenburg

Investigational Site Number : 7520001, Huddinge

Investigational Site Number : 7520002, Lund

Investigational Site Number : 7920006, Adana

Investigational Site Number : 7920002, Ankara

Investigational Site Number : 7920004, Ankara

Investigational Site Number : 7920001, Ankara

Investigational Site Number : 8260006, Cardiff

Investigational Site Number : 8260002, London

Investigational Site Number : 8260003, Leeds

Investigational Site Number : 8260001, Manchester

Investigational Site Number : 8260004, Newcastle upon Tyne